Centogene N.V. Market Cap ($3.48 Million)
Market Cap & Net Worth: Centogene N.V. (CNTGF)
Centogene N.V. market cap. Centogene N.V. (NASDAQ:CNTGF) has a market capitalization of $3.48 Million ($3.48 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29205 globally and #5981 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Centogene N.V.'s stock price $0.12 by its total outstanding shares 29000137 (29.00 Million). Also see Centogene N.V. (CNTGF) cash flow conversion for how efficiently the company converts equity into cash flow.
Centogene N.V. Market Cap History (2019–2026)
Centogene N.V. market cap history from 2019 to 2026. Data shows change from $292.03 Million to $3.48 Million (-50.03% CAGR). Check Centogene N.V. (CNTGF) stock price for real-time trading data and today's change.
Centogene N.V. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Centogene N.V.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Centogene N.V. to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.72x
Centogene N.V.'s market cap is 0.72 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $312.62 Million | $38.45 Million | -$21.99 Million | 8.13x | N/A |
| 2021 | $151.61 Million | $42.23 Million | -$46.25 Million | 3.59x | N/A |
| 2022 | $26.97 Million | $47.47 Million | -$31.84 Million | 0.57x | N/A |
| 2023 | $34.80 Million | $48.54 Million | -$35.53 Million | 0.72x | N/A |
Competitor Companies of CNTGF by Market Capitalization
Companies near Centogene N.V. in the global market cap rankings as of November 4, 2026. Also see CNTGF current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Centogene N.V. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #142 globally with a market cap of $162.54 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #479 globally with a market cap of $56.02 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #546 globally with a market cap of $48.96 Billion USD ( CN¥334.59 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $698.34 |
| #142 | Danaher Corporation | NYSE:DHR | $162.54 Billion | $230.11 |
| #479 | Natera Inc | NASDAQ:NTRA | $56.02 Billion | $388.63 |
| #546 | WuXi AppTec Co Ltd | SHG:603259 | $48.96 Billion | CN¥135.28 |
Market Capitalization of Centogene N.V. (2019–2026)
Market capitalization of Centogene N.V. from 2019 to today. Between 2019 and today, Centogene N.V.'s market cap moved from $292.03 Million to $ 3.48 Million, with a yearly change of -50.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.48 Million | +14.29% |
| 2025 | $3.05 Million | -19.23% |
| 2024 | $3.77 Million | -89.17% |
| 2023 | $34.80 Million | +29.03% |
| 2022 | $26.97 Million | -82.21% |
| 2021 | $151.61 Million | -51.50% |
| 2020 | $312.62 Million | +7.05% |
| 2019 | $292.03 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Centogene N.V. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.48 Million USD |
| MoneyControl | $3.48 Million USD |
| MarketWatch | $3.48 Million USD |
| marketcap.company | $3.48 Million USD |
| Reuters | $3.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Centogene N.V.
Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA … Read more